메뉴 건너뛰기




Volumn 27, Issue 3, 2007, Pages 99-102

Nephrological manifestations of patients with Fabry disease in Argentina;Manifestaciones nefrológicas de pacientes con Enfermedad de Fabry en Argentina

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOLIPID;

EID: 36348975206     PISSN: 03263428     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (2)

References (10)
  • 1
    • 0014216741 scopus 로고
    • Enzymatic defect in Fabry disease
    • Brady RO, Gal AE, Bradley RM et al. Enzymatic defect in Fabry disease. N Engl J Med 1967: 276: 1163-1167.
    • (1967) N Engl J Med , vol.276 , pp. 1163-1167
    • Brady, R.O.1    Gal, A.E.2    Bradley, R.M.3
  • 2
    • 1642496926 scopus 로고    scopus 로고
    • Dehout F, Schwarting A, Beck M, et al. Effects of enzyme replacement therapy with agalsidase alfa on glomerular filtration rate in patients with Fabry disease: preliminary data. Acta Paediatr Suppl. 2003; 92:14-5; discussion 5.
    • Dehout F, Schwarting A, Beck M, et al. Effects of enzyme replacement therapy with agalsidase alfa on glomerular filtration rate in patients with Fabry disease: preliminary data. Acta Paediatr Suppl. 2003; 92:14-5; discussion 5.
  • 3
    • 0014964372 scopus 로고
    • Fabry disease. Alpha galactosidase deficiency
    • Kint JA. Fabry disease. Alpha galactosidase deficiency. Science 1970: 167: 1268-1269.
    • (1970) Science , vol.167 , pp. 1268-1269
    • Kint, J.A.1
  • 4
    • 0033585476 scopus 로고    scopus 로고
    • Prevalence of lysosomal storage disorders
    • Meikle PJ, Hopwood JJ, Clague AE et al. Prevalence of lysosomal storage disorders. JAMA 1999: 281: 249-254.
    • (1999) JAMA , vol.281 , pp. 249-254
    • Meikle, P.J.1    Hopwood, J.J.2    Clague, A.E.3
  • 5
  • 6
    • 0034766525 scopus 로고    scopus 로고
    • Anderson-Fabry disease: Clinical manifestations and impact of disease in a cohort of 98 hemizygous males
    • MacDermot KD, Holmes A, Miners AH. Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males. J Med Genet 2001: 38: 750-760.
    • (2001) J Med Genet , vol.38 , pp. 750-760
    • MacDermot, K.D.1    Holmes, A.2    Miners, A.H.3
  • 7
    • 0035816007 scopus 로고    scopus 로고
    • Enzyme replacement therapy in Fabry disease: A randomized controlled trial
    • Schiffmann R, Kopp JB, Austin HA 3rd et al. Enzyme replacement therapy in Fabry disease: a randomized controlled trial. JAMA 2001; 285: 2743-9.
    • (2001) JAMA , vol.285 , pp. 2743-2749
    • Schiffmann, R.1    Kopp, J.B.2    Austin 3rd, H.A.3
  • 8
    • 0036145366 scopus 로고    scopus 로고
    • Patients with Fabry disease on dialysis in the United States
    • Thadhani R, Wolf M, West ML, et al: Patients with Fabry disease on dialysis in the United States. Kidney Int 61:249-255, 2002.
    • (2002) Kidney Int , vol.61 , pp. 249-255
    • Thadhani, R.1    Wolf, M.2    West, M.L.3
  • 10
    • 85068243443 scopus 로고    scopus 로고
    • Registry
    • suppl 7
    • Registry. Nephrol Dial Transplant 11:S4-S20, 1996 (suppl 7).
    • (1996) Nephrol Dial Transplant , vol.11


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.